Alfresa joins Hiroshima drone pact: what it means for Alfresa stock
Published on 10/20/2026 at 04:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSOperational strain meets expansion
- TS Alfresa joined a Hiroshima drone agreement on October 15, 2026.
- First-quarter fiscal 2027 revenue reached JPY 788.96 billion, up 4.10 percent year over year.
- Alfresa stock was last at JPY 2,341 on October 20, 2026 at 11:25 a.m. JST.
Alfresa Holdings Corporation's subsidiary TS Alfresa joined a Hiroshima drone agreement on October 15, 2026, adding a logistics and emergency-response angle to the group's healthcare network. PR Times reported that the agreement with Hiroshima Prefecture covers cooperation using unmanned aircraft during disasters.
What the pact means
The agreement gives investors a concrete example of how Alfresa is extending its distribution capabilities beyond conventional pharmaceutical wholesaling. The financial weight remains to be demonstrated, but the operational link is clear: TS Alfresa is part of the Hiroshima Drone Utilization Promotion Council, while the prefecture provides the public-sector setting.
The latest operating figures show why execution matters. In the first quarter of fiscal 2027, revenue rose 4.10 percent year over year to JPY 788.96 billion, while net income fell 50.50 percent to JPY 2.48 billion. Smart Stock Notes attributed the pressure to drug-price revisions, logistics and labor costs, depreciation at a new manufacturing facility, and investment-related losses.
Margin pressure remains visible
Operating profit dropped 19.60 percent to JPY 5.60 billion in the same period, even as the medical-products wholesale segment generated JPY 709.80 billion of revenue, up 4.60 percent. The segment accounted for 89.90 percent of group revenue, making its margin performance central to the investment case. Alfresa kept its full-year outlook unchanged, including an annual dividend forecast of JPY 71.00 per share, according to Smart Stock Notes.
Three dated steps for investors
Alfresa's recent chronology runs from a JPY 15.00 billion share repurchase announced in May 2026, to the fiscal 2027 first-quarter results released on August 5, 2026, and the Hiroshima drone agreement dated October 15, 2026. The sequence combines shareholder returns, weaker profit conversion, and a new logistics application.
Which dates come next?
Simply Wall St lists November 9, 2026 as the next earnings date. The same source lists December 7, 2026 as the payment date for the JPY 35.00 interim dividend.
Tokyo quote and company scale
Alfresa was last at JPY 2,341 on the Tokyo Stock Exchange on October 20, 2026 at 11:25 a.m. JST. Its market capitalization was JPY 410.6 billion, while the 52-week range was JPY 2,106.50 to JPY 2,685.50. Global Banking and Finance identifies Alfresa as a Tokyo Stock Exchange healthcare company with ticker 2784.
Alfresa stock key facts
- Company: Alfresa Holdings Corporation
- ISIN: JP3126340003
- Ticker: 2784
- Primary exchange: Tokyo Stock Exchange
- Price Tokyo Stock Exchange: JPY 2,341 as of October 20, 2026, 11:25 a.m. JST
- Market capitalization: JPY 410.6 billion as of October 20, 2026
- 52-week range: JPY 2,106.50-2,685.50 as of October 20, 2026
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: Nikkei 225
- Next earnings date: November 9, 2026
Market context: Market report Nikkei 225.
